ArticleSurgical case reports2026
Isolated Port-Site Recurrence after Laparoscopic Distal Pancreatectomy for Pancreatic Adenosquamous Carcinoma: A Case Report.
Article in Surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMinimally invasive pancreatectomy has become widely adopted worldwide. However, its oncologic safety in malignant diseases remains a matter of ongoing debate, including atypical patterns of tumor recurrence. Port-site recurrence (PSR) is a rare but clinically relevant condition following minimally invasive oncologic surgery. Although several mechanisms, including tumor manipulation and pneumoperitoneum-related factors, have been proposed, the underlying pathogenesis remains unclear. Especially in pancreatic cancer, reports of PSR after minimally invasive surgery are extremely limited, and its optimal management has not been established. CASE PRESENTATION: A 75-year-old man was referred to our institution with a pancreatic tail tumor detected on CT during evaluation of epigastric pain. Contrast-enhanced CT and endoscopic US-guided fine-needle aspiration biopsy led to a diagnosis of pancreatic cancer, and laparoscopic distal pancreatectomy was performed as upfront surgery. Intraoperatively, no peritoneal dissemination was observed, and peritoneal cytology was negative. The pancreatic tail tumor demonstrated invasion of the anterior pancreatic serosa. Histopathological examination revealed adenosquamous carcinoma composed of approximately 70% squamous cell carcinoma and 30% adenocarcinoma components. The postoperative course was uneventful, and adjuvant chemotherapy with S-1 was administered. Approximately 6 months after surgery, the patient developed a painful mass at the left lower trocar site. Contrast-enhanced CT and abdominal ultrasonography revealed a 3 × 4-cm irregular mass within the rectus abdominis muscle at the corresponding trocar site, with no evidence of distant metastasis. The lesion was considered an isolated PSR based on multidisciplinary discussion, and surgical resection was performed. Intraoperative findings confirmed the absence of peritoneal dissemination, and the tumor was completely resected. Pathological examination revealed metastatic squamous cell carcinoma, consistent with the squamous component of the primary tumor, leading to a diagnosis of PSR. The patient remains free of recurrence 6 months after resection.
conclusionsPSR after minimally invasive surgery for pancreatic cancer is extremely rare. In this case, tumor biology, especially the squamous component in adenosquamous carcinoma, may play a key role in its development. Surgical resection may be considered in carefully selected patients with isolated PSR, although further studies are required to clarify its clinical significance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.